A Comprehensive Overview of <i>Candida albicans</i> as the Leading Pathogen in Vulvovaginal Candidiasis. [PDF]
Srb N +6 more
europepmc +1 more source
Regulatory gaps in over-the-counter antifungal access for vulvovaginal candidiasis in Uganda: A policy analysis framework. [PDF]
Jonani B, Kwizera R.
europepmc +1 more source
Cortical evidence accumulation for visual perception occurs irrespective of reports. [PDF]
Stockart F +14 more
europepmc +1 more source
New insights toward personalized therapies for vulvovaginal candidiasis and vaginal co-infections. [PDF]
De Seta F, Warris A, Roselletti E.
europepmc +1 more source
Fast Mode and CU Splitting Decision for Intra Prediction in VVC SCC
Dayong Wang +6 more
openalex +2 more sources
<i>Candida auris</i> persists in the vaginal microaerobic niche in the absence of interleukin-17A. [PDF]
Abe M +10 more
europepmc +1 more source
Ibrexafungerp: Mechanism of Action, Clinical, and Translational Science. [PDF]
Walley AH +3 more
europepmc +1 more source
Real-World Ibrexafungerp Use Patterns Among Patients with Commercial Health Insurance, United States, 2021-2023. [PDF]
Benedict K, Smith DJ, Gold JAW.
europepmc +1 more source
Prevalence of Candida and Other Yeasts in Vulvovaginal Infections during Pregnancy: A 10-Year Serbian Survey. [PDF]
Arsić Arsenijević V +5 more
europepmc +1 more source

